An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.

Simon J Park(Illinois College), Kiran Kumar Velpula(Illinois College), Ryan R. Wilbur(Illinois College), Arpit Sahoo(Illinois College), Charles P. Cain(Illinois College), Maheedhara R. Guda(University of Illinois Urbana-Champaign), Sankeerth R Kallu(Illinois College), Chase P. Smith(Illinois College), Andrew J. Tsung(Illinois College), Srijan Valasapalli(Illinois College)
PubMed
January 1, 2018
Cited by 106

Related Papers

B7-H3 role in the immune landscape of cancer.
|PubMed|2017|175
Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.
|PubMed|2016|98
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
|PeerJ|2020|90
Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept
|CNS Oncology|2016|81
Immunopathology of galectin-3: an increasingly promising target in COVID-19
|F1000Research|2020|77